Barrow Robert
Definium Therapeutics, Inc. · Chief Executive Officer
Barrow Robert is listed in public filings as director, officer: Chief Executive Officer. This Barrow Robert insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Definium Therapeutics, Inc. (DFTX). Investors use Barrow Robert's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| $113k15.7k shares | SellJun 25, 2024 | $7.22 | -- | |
| $3.2k500 shares | BuyAug 19, 2024 | $6.31 | -- | |
| $3.1k500 shares | BuyAug 20, 2024 | $6.12 | -- | |
| $118k19.8k shares | SellSep 25, 2024 | $5.98 | -- | |
| $142k19.1k shares | SellDec 26, 2024 | $7.43 | -- | |
| $143k21.2k shares | SellMar 25, 2025 | $6.74 | -- | |
| $180k26.5k shares | SellJun 25, 2025 | $6.80 | -- | |
| $252k25.8k shares | SellSep 25, 2025 | $9.77 | -- | |
| $339k25.8k shares | SellDec 26, 2025 | $13.15 | -- |